Clinical Research Directory
Browse clinical research sites, groups, and studies.
FCI-Glioblastoma Study
Sponsor: University of Aberdeen
Summary
The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can tell the difference between tumour growth (progression) and 'pseudo-progression' (which looks like tumour but is not cancerous tissue) in patients with glioblastoma. The main question it aims to answer is: • Can FCI differentiate glioblastoma progression from pseudo-progression? Participants will undergo a standard MRI scan and an FCI scan, three times during the study. One before starting adjuvant chemotherapy, another one after three cycles and one at the end of treatment.
Official title: Applying New MRI Technology to Improve Outcomes From Chemoradiotherapy Treatment for Adult Patients With Glioblastoma
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
18
Start Date
2026-02
Completion Date
2027-12
Last Updated
2026-03-02
Healthy Volunteers
No
Conditions
Interventions
Baseline Field-Cycling Imaging research scan
FCI scan at baseline
Baseline 3T MRI research scan
MRI scan at baseline
Second Field-Cycling Imaging research scan
FCI scan after three cycles of chemotherapy
Second 3T MRI research scan
MRI scan after three cycles of chemotherapy
Final Field-Cycling Imaging research scan
FCI scan at the end of chemotherapy
Final 3T MRI research scan
MRI scan at the end of chemotherapy
Locations (1)
University of Aberdeen
Aberdeen, United Kingdom